| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |